DexCom, Inc. (DXCM) is listed on NASDAQ in Medical Device Stocks. It is $90.82, +1.71%, with a $34.3B market cap. RSI is 63.9, near overbought. The latest reported quarter beat estimates. Insiders were net sellers across the listed trades.
Technical Analysis
RSI (14) 63.9 Near Overbought
Market Cap $34.3B
Volume 3.6M
Fundamentals — 10-Q Q2 2026
Revenue $2.5B
Net Income $448.6M
EPS $1.15
Gross Margin 63.2%
Operating Margin 22.9%
Net Margin 17.9%
P/E Ratio 79.0x
Earnings
Recent Insider Trades
| Name | Title | Type | Shares | Price | Value | Date |
|---|---|---|---|---|---|---|
| Stern Sadie | EVP Chief People & Culture Off | Sell | 2,565 | $88.37 | $226,669 | 2026 Aug 27 |
| Sayer Kevin R | Executive Chair | Sell | 26,756 | $90.01 | $2.4M | 2026 Aug 20 |
| Brown Michael Jon | EVP Chief Legal Compliance Off | Sell | 1,700 | $91.93 | $156,281 | 2026 Aug 14 |
| Heller Bridgette P | Director | Sell | 1,012 | $88.29 | $89,349 | 2026 Aug 12 |
| Foletta Mark G | Director | Sell | 4,000 | $82.66 | $330,640 | 2026 Aug 3 |
| Sayer Kevin R | Executive Chair | Sell | 26,756 | $76.32 | $2.0M | 2026 Jul 20 |
| Brown Michael Jon | EVP Chief Legal Compliance Off | Sell | 1,700 | $74.42 | $126,514 | 2026 Jul 15 |
| Sayer Kevin R | Executive Chair | Sell | 26,756 | $72.00 | $1.9M | 2026 Jul 6 |
| Brown Michael Jon | EVP Chief Legal Compliance Off | Sell | 1,700 | $75.55 | $128,435 | 2026 Jun 15 |
| Foletta Mark G | Director | Sell | 4,000 | $74.13 | $296,540 | 2026 Jun 15 |
| Coleman Jon | EVP, Chief Commercial Officer | Sell | 9,823 | $73.56 | $722,628 | 2026 Jun 4 |
| Sayer Kevin R | Executive Chair | Sell | 26,759 | $72.00 | $1.9M | 2026 May 21 |
| Brown Michael Jon | EVP, Chief Legal Officer | Sell | 1,700 | $59.91 | $101,847 | 2026 May 15 |
| Heller Bridgette P | Director | Sell | 1,012 | $60.01 | $60,730 | 2026 May 12 |
| Brown Michael Jon | EVP, Chief Legal Officer | Sell | 1,700 | $63.04 | $107,168 | 2026 Apr 15 |
| Brown Michael Jon | EVP, Chief Legal Officer | Sell | 1,700 | $64.85 | $110,245 | 2026 Mar 16 |
| Collins Richard Alexander | Director | Sell | 2,906 | $59.05 | $171,599 | 2025 Nov 14 |
| Heller Bridgette P | Director | Sell | 1,012 | $58.07 | $58,767 | 2025 Nov 12 |
| Leach Jacob Steven | President & COO | Buy | 18,200 | $55.04 | $1.0M | 2025 Nov 10 |
| Collins Richard Alexander | Director | Sell | 3,948 | $55.17 | $217,811 | 2025 Nov 10 |
Other Medical Device Stocks
| Ticker | Price | RSI | Mkt Cap |
|---|---|---|---|
| | $46.83 | 45.9 | $67.9B |
| | $330.77 | 51.3 | $126.9B |
| | $91.21 | 57.7 | $116.7B |
| | $189.57 | 74.2 | $51.6B |
| | $90.19 | 55.1 | $52.0B |
| | $71.72 | 56.2 | $32.6B |
| | $35.28 | 47.1 | $29.6B |
| | $145.15 | 42.3 | $10.1B |
Take DXCM further
- Browse Medical Device Stocks for the rest of the group, with what the businesses in it have in common and where they differ.
- Put DXCM in a portfolio and see what it does to total return, drawdown, and how the rest of your holdings move with it. Compares against the S&P 500 over the same days, free and without an account.
- Screen for others like it by RSI, valuation, market cap, and insider activity.
- Check the earnings calendar for when DexCom, Inc. next reports.
Set alerts on DXCM
Get notified when DexCom, Inc. hits your price targets or technical conditions are met.
Get Started Free